Gloomy outlook may be genetic - KFDA - NewsChannel 10 / Amarillo News, Weather, Sports

Gloomy outlook may be genetic

Updated: Oct 18, 2013 09:22 AM
© Hemera / Thinkstock © Hemera / Thinkstock

FRIDAY, Oct. 18 (HealthDay News) -- Some people might be genetically inclined to be negative, according to a new study.

Researchers found that a specific gene variant can cause people to perceive emotional events -- especially negative ones -- more vividly than others. Previous research showed that this same gene variant plays a role in the formation of emotional memories.

In this study, 200 volunteers were shown positive, negative and neutral words in rapid succession. Those with the ADRA2b gene variant were more likely to identify negative words than others, according to the study, which was published recently in the journal Psychological Science.

"These individuals may be more likely to pick out angry faces in a crowd of people," Professor Rebecca Todd, from the University of British Columbia's department of psychology, said in a university news release. "Outdoors, they might notice potential hazards -- places you could slip, loose rocks that might fall -- instead of seeing the natural beauty."

"[These findings] suggest people experience emotional aspects of the world partly through gene-colored glasses, and that biological variations at the genetic level can play a significant role in individual differences in perception," she said.

The results offer new insight into how genetics -- combined with other factors such as education, culture and mood -- can affect how people see the world around them, the researchers said.

They plan further research focusing on different ethnic groups. It's believed that more than half of whites have the ADRA2b gene variant, while it is much less common in other ethnic groups. For example, a recent study found that only 10 percent of Rwandans had the gene variant, the researchers said.

More information

The American Academy of Family Physicians explains how emotions affect your health.

Copyright © 2013 HealthDay. All rights reserved.

  • Health WatchMore>>

  • $1,000 Sovaldi now hepatitis treatment of choice

    $1,000 Sovaldi now hepatitis treatment of choice

    Thursday, July 31 2014 9:25 PM EDT2014-08-01 01:25:37 GMT
    A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.
    The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million.
  • See-through mice reveal details of inner anatomy

    See-through mice reveal details of inner anatomy

    Thursday, July 31 2014 5:23 PM EDT2014-07-31 21:23:53 GMT
    Researchers have found a way to make see-through mice, but you won't find these critters scampering in your kitchen.
    Researchers have found a way to make see-through mice, but you won't find these critters scampering in your kitchen.
  • House approves VA health care overhaul

    House approves VA health care overhaul

    Wednesday, July 30 2014 9:12 PM EDT2014-07-31 01:12:40 GMT
    With a new Veterans Affairs secretary in place and an August recess looming, Congress is moving quickly to approve a compromise bill to refurbish the VA and improve veterans' health care.
    The House overwhelmingly approved a landmark bill Wednesday to help veterans avoid long waits for health care that have plagued the Veterans Affairs Department for years.
*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.